Pharmaceutical development of film-coated mini-tablets with losartan potassium for Epidermolysis Bullosa
first_published_at:March 5, 2022, midnight / date_published:March 5, 2022
Papers
-
05/03/2022 -
by
Valentinë Elezaj,
Ard Lura,
Luis Canha,
Jörg Breitkreutz
Epidermolysis bullosa is a genetically heterogeneous skin fragility disorder that manifests with multiorgan involvement, often evident in newborn children. The condition leads to severe progressive fibrosis following skin blistering, mucosal …
